Redbock - an NES Fircroft company · 8 hours ago
Senior Statistical Programmer
Redbock is an NES Fircroft company specializing in the biotech sector, and they are seeking a Senior Statistical Programmer. The role involves performing quality control and validation of analysis datasets, developing SAS macros, and collaborating with various teams to support clinical studies.
Responsibilities
Perform QC and validation of vendor-delivered analysis datasets, tables, listings, and figures (TLFs)
Develop and maintaining SAS macros to support analysis datasets (SDTM/ADaM), TFLs, and regulatory (BLA) submissions
Conduct limited in-house programming, primarily ADaM dataset development, to ensure vendor quality and compliance
Collaborate closely with internal Biostatistics, Data Management, and Clinical teams to support ongoing clinical studies
Ensure adherence to CDISC standards (ADaM and SDTM) and company programming best practices
Qualification
Required
8+ years of hands-on statistical programming experience, preferably with a small biotech or pharma company
Proven programming experience supporting Phase III clinical trials and BLA (Biologics License Application) submissions
Must have advanced SAS macro development skills - experience developing and maintaining SAS macros to support analysis datasets (SDTM/ADaM), TFLs, and regulatory submissions
Strong working knowledge of CDISC ADaM and SDTM standards, as well as TLF programming
Company
Redbock - an NES Fircroft company
Redbock is a consultancy that delivers customized resourcing solutions to pharmaceutical, biotechnology, medical device and diagnostics companies.
H1B Sponsorship
Redbock - an NES Fircroft company has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (8)
2024 (5)
2023 (1)
2022 (1)
2021 (8)
2020 (9)
Funding
Current Stage
Growth StageTotal Funding
unknown2018-06-20Acquired
Company data provided by crunchbase